Evoke PharmaEVOK
13F holders, Q1 2024 (March 31)15holders
1famous investor
$0.61avg. 13F price*
At the end of Q1 2024, 15 institutions reported holding Evoke Pharma Inc. (EVOK) in their 13F filings. The largest holders were AIGH Capital Management LLC ($516K), Bleichroeder LP ($503K) and Altium Capital Management LLC ($442K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Evoke Pharma Inc.
- CUSIP
- 30049G203
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.9M |
| Exits | 2 | $2 |
Ownership 15 holders
| AIGH Capital Management LLC | 0.25% | New | 846,564 | $516K |
| Bleichroeder LP | 0.13% | New | 825,000 | $503K |
| Altium Capital Management LLC | 0.20% | New | 724,942 | $442K |
| Nantahala Capital Management, LLC | 0.04% | New | 675,000 | $412K |
| Vanguard Group Inc. | 0.00% | No change | 29,851 | $18K |
| Geode Capital Management, LLC | 0.00% | No change | 27,065 | $17K |
| Goldman Sachs Group Inc. | 0.00% | New | 13,471 | $8K |
| Millennium Management | 0.00% | New | 10,869 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +14.9% | 7,405 | $5K |
| BlackRock Inc. | 0.00% | Reduce -0.6% | 1,464 | $893 |
| UBS Group AG | 0.00% | Reduce -62.0% | 1,107 | $675 |
| Morgan Stanley | 0.00% | No change | 375 | $229 |
| NewEdge Advisors, LLC | 0.00% | No change | 208 | $127 |
| Wells Fargo & Company | 0.00% | Add +153.8% | 66 | $40 |
| Royal Bank of Canada | 0.00% | No change | 28 | $0 |
"% of holder's portfolio" is EVOK's weight in each manager's 13F, not the share of Evoke Pharma Inc. the manager owns.